Solutions for Drug Developers
By revealing function in an unprecedented way with our proprietary technology, Nodality enables smart drug development throughout the full R&D process. Our customers realize the benefits of better-informed decisions across a very broad spectrum of activities, including:
Better Informed Decisions
Disease Profiling - Fundamental to any discovery and development program is a solid understanding of the biology underlying the disease state such as:
- Disease-specific profiling of signaling within defined cell populations and subsets
- Identification of new targets
- Identification of cell–cell interactions relevant to disease and treatment effects
- Identification of subtypes of disease to guide early-stage drug development and patient selection in clinical trials
Drug Profiling - Facilitate rational development of therapeutic agents, including small molecules and biologics:
- Uncover on-target and off-target mechanisms of action
- Compare targeting, potency and selectivity of drugs
- Creation of a rational basis for combination therapy to optimize efficacy and minimize undesirable drug interactions
Clinical Development - Enhance the chances for clinical and market success:
- Enablement of rational combination therapies
- PD markers in whole blood
- Clinical trial design directed by defined patient groups
- Facilitate competitive differentiation
- Companion diagnostics
Life Cycle Management - Achieve additional benefits after a drug has reached the market:
- Biological basis for competitive positioning
- Drug expansion and repurposing
- Diagnostic and monitoring tests
Solutions for drug developers across disease areas
Nodality’s scientific and informatics teams have expertise in achieving solutions across a variety of disease areas, including oncology, autoimmune and inflammatory diseases. By applying SCNP™, Nodality offers broad sets of capabilities within each therapeutic area that addresses BioPharma challenges in Oncology, Immunology and other areas.